Jafron Biomedical Co.,Ltd. (SHE:300529)
China
· Delayed Price · Currency is CNY 26.37
-0.05 (-0.19%)
Apr 3, 2025, 3:04 PM CST
Jafron Biomedical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 2, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Market Capitalization | 20,420 | 17,755 | 24,741 | 42,653 | 54,196 | 30,077 | Upgrade
|
Market Cap Growth | 39.40% | -28.23% | -41.99% | -21.30% | 80.19% | 73.68% | Upgrade
|
Enterprise Value | 19,328 | 16,803 | 23,822 | 41,394 | 52,930 | 29,001 | Upgrade
|
Last Close Price | 26.37 | 21.91 | 29.82 | 50.32 | 63.59 | 35.19 | Upgrade
|
PE Ratio | 26.05 | 40.68 | 27.81 | 35.64 | 61.92 | 52.69 | Upgrade
|
Forward PE | 18.79 | 20.46 | 14.20 | 31.28 | 53.74 | 41.80 | Upgrade
|
PS Ratio | 7.95 | 9.24 | 9.93 | 15.94 | 27.78 | 21.01 | Upgrade
|
PB Ratio | 6.21 | 5.63 | 6.89 | 12.61 | 19.13 | 13.86 | Upgrade
|
P/TBV Ratio | 7.89 | 5.85 | 7.20 | 13.27 | 20.28 | 14.67 | Upgrade
|
P/FCF Ratio | 23.40 | 26.52 | 60.65 | 59.91 | 90.27 | 82.90 | Upgrade
|
P/OCF Ratio | 20.92 | 19.37 | 27.99 | 34.14 | 56.60 | 51.55 | Upgrade
|
EV/Sales Ratio | 7.34 | 8.74 | 9.56 | 15.47 | 27.13 | 20.26 | Upgrade
|
EV/EBITDA Ratio | 18.56 | 29.40 | 23.92 | 30.15 | 52.81 | 45.72 | Upgrade
|
EV/EBIT Ratio | 20.70 | 34.79 | 25.71 | 31.27 | 54.82 | 47.98 | Upgrade
|
EV/FCF Ratio | 22.15 | 25.10 | 58.40 | 58.14 | 88.16 | 79.93 | Upgrade
|
Debt / Equity Ratio | 0.49 | 0.53 | 0.36 | 0.27 | - | - | Upgrade
|
Debt / EBITDA Ratio | 1.55 | 2.91 | 1.28 | 0.67 | - | - | Upgrade
|
Debt / FCF Ratio | 1.85 | 2.50 | 3.13 | 1.29 | - | - | Upgrade
|
Asset Turnover | 0.48 | 0.35 | 0.49 | 0.67 | 0.68 | 0.63 | Upgrade
|
Inventory Turnover | 1.53 | 1.05 | 1.61 | 2.54 | 2.70 | 2.57 | Upgrade
|
Quick Ratio | 3.36 | 3.49 | 3.91 | 7.21 | 5.44 | 5.49 | Upgrade
|
Current Ratio | 3.77 | 3.99 | 4.59 | 7.91 | 6.01 | 5.94 | Upgrade
|
Return on Equity (ROE) | 24.75% | 12.63% | 25.26% | 38.47% | 34.89% | 29.22% | Upgrade
|
Return on Assets (ROA) | 10.53% | 5.51% | 11.33% | 20.61% | 21.13% | 16.62% | Upgrade
|
Return on Capital (ROIC) | 11.94% | 6.23% | 12.63% | 23.19% | 24.12% | 19.41% | Upgrade
|
Return on Capital Employed (ROCE) | 19.80% | 10.20% | 19.70% | 29.90% | 33.50% | 27.10% | Upgrade
|
Earnings Yield | 3.94% | 2.46% | 3.60% | 2.81% | 1.62% | 1.90% | Upgrade
|
FCF Yield | 4.27% | 3.77% | 1.65% | 1.67% | 1.11% | 1.21% | Upgrade
|
Dividend Yield | 1.52% | 1.83% | 2.25% | 1.79% | 1.04% | 1.35% | Upgrade
|
Payout Ratio | 42.08% | 128.71% | 82.00% | 44.37% | 43.17% | 43.97% | Upgrade
|
Buyback Yield / Dilution | 0.51% | 0.08% | 1.12% | 0.89% | -2.22% | -0.68% | Upgrade
|
Total Shareholder Return | 2.03% | 1.91% | 3.36% | 2.67% | -1.18% | 0.66% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.